Tag Archives: Mount Sinai Innovation Partners

Hercules Capital Provides $30MM Debt Facility to HiberCell

HiberCell, a biotechnology company developing therapeutics for the prevention of cancer relapse and metastasis, closed on a $30 million debt facility with Hercules Capital. In addition, HiberCell completed a Series B financing round for gross proceeds of $67.4 million.